Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$1.13B |
| 2 |
Sea Limited
SE
|
+$1.11B |
| 3 |
Amazon
AMZN
|
+$958M |
| 4 |
Morgan Stanley
MS
|
+$871M |
| 5 |
PG&E
PCG
|
+$840M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$1.35B |
| 2 |
Mastercard
MA
|
+$1.22B |
| 3 |
JPMorgan Chase
JPM
|
+$1.09B |
| 4 |
Vale
VALE
|
+$724M |
| 5 |
Diamondback Energy
FANG
|
+$724M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.89% |
| 2 | Communication Services | 15.06% |
| 3 | Healthcare | 14.45% |
| 4 | Consumer Discretionary | 13.58% |
| 5 | Financials | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIXT
226
DELISTED
TELUS International
TIXT
| $244M | 0.06% |
6,955,886
+4,396,437
| +172% | +$142M |
|
227
Icon
ICLR
$12.9B
| $241M | 0.06% |
+919,751
| New | +$224M |
|
|
SRCL
228
DELISTED
Stericycle Inc
SRCL
| $238M | 0.06% |
3,504,851
+567,582
| +19% | +$39.2M |
|
229
McCormick & Company Non-Voting
MKC
$14.2B
| $237M | 0.06% |
2,926,307
+340
| +0% | +$29.2K |
|
230
Target
TGT
$69.9B
| $236M | 0.06% |
1,032,720
| – | – |
|
231
SouthState Bank Corp
SSB
$10.7B
| $235M | 0.05% |
3,151,622
+1,203,544
| +62% | +$85.7M |
|
232
Franklin Resources
BEN
$17.1B
| $235M | 0.05% |
7,911,806
-200,975
| -2% | -$6.27M |
|
233
Sarepta Therapeutics
SRPT
$1.94B
| $235M | 0.05% |
2,542,191
-2,208,578
| -46% | -$170M |
|
234
Arista Networks
ANET
$265B
| $232M | 0.05% |
10,811,904
-7,039,536
| -39% | -$161M |
|
235
Tesla
TSLA
$1.29T
| $219M | 0.05% |
845,871
-135,483
| -14% | -$31.9M |
|
236
CarMax
KMX
$8.33B
| $219M | 0.05% |
1,708,426
-336
| -0% | -$44.7K |
|
237
Monster Beverage
MNST
$90.1B
| $215M | 0.05% |
9,691,244
-4,368
| -0% | -$103K |
|
238
RELX
RELX
$60.2B
| $215M | 0.05% |
7,449,967
+33
| +0% | +$972 |
|
239
Asana
ASAN
$2.07B
| $215M | 0.05% |
2,070,105
-654,027
| -24% | -$54.3M |
|
240
Cullen/Frost Bankers
CFR
$10.4B
| $215M | 0.05% |
1,810,449
-674
| -0% | -$75.2K |
|
241
GSK
GSK
$101B
| $213M | 0.05% |
4,455,613
+574
| +0% | +$28.8K |
|
242
Quince Therapeutics
QNCX
$31.8M
| $212M | 0.05% |
11,579
| – | – |
|
243
Coursera
COUR
$1.48B
| $212M | 0.05% |
6,702,898
+931,805
| +16% | +$35.1M |
|
244
Xcel Energy
XEL
$49.1B
| $211M | 0.05% |
3,376,045
+422
| +0% | +$28.5K |
|
245
Walt Disney
DIS
$178B
| $208M | 0.05% |
1,231,575
| – | – |
|
246
Paylocity
PCTY
$7.73B
| $206M | 0.05% |
735,262
+558,180
| +315% | +$134M |
|
|
EVRI
247
DELISTED
Everi Holdings
EVRI
| $205M | 0.05% |
8,495,345
+551,886
| +7% | +$12.6M |
|
248
Nutrien
NTR
$32.1B
| $203M | 0.05% |
3,132,330
+472
| +0% | +$28.9K |
|
|
EA
249
DELISTED
Electronic Arts
EA
| $202M | 0.05% |
1,420,128
-77,031
| -5% | -$10.8M |
|
250
Bentley Systems
BSY
$10.8B
| $201M | 0.05% |
3,322,295
-78,444
| -2% | -$5.01M |
|
Similar funds
Capital Research Global Investors's Q3 2021 Portfolio in Review
As of Q3 2021, Capital Research Global Investors held 460 positions worth $429B, down 0.2% from $430B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital Research Global Investors's Q3 2021 filing shows 23 new, 187 increased, 164 reduced and 19 closed positions. Its largest new stake was Block Inc: 1,884,689 shares worth $452M. The largest sale was EOG Resources, an estimated $1.35B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Communication Services and Healthcare.
- Capital Research Global Investors's largest Q3 2021 buy was Block Inc: 1,884,689 shares worth $452M.
- Capital Research Global Investors added most to GE Aerospace in Q3 2021, an estimated $1.13B increase.
- Capital Research Global Investors's biggest Q3 2021 reduction was EOG Resources, cutting an estimated $1.35B.
- Capital Research Global Investors fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $380M.
- Capital Research Global Investors's ten largest holdings make up 30% of its $429B portfolio in Q3 2021.
- Capital Research Global Investors opened 23 new positions and closed 19 in Q3 2021.
- Capital Research Global Investors's portfolio value fell 0.2% quarter-over-quarter to $429B.
Based on Capital Research Global Investors's 13F filing for Q3 2021, filed 15 Nov 2021.